314 filings
Page 3 of 16
8-K
hd6k7y4ll ppzjzqp
10 May 17
Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2017
12:00am
8-K
9ez3vdtl
10 May 17
Array BioPharma Announces Positive Top-Line Results from Part 2 of the Phase 3 COLUMBUS Study of Binimetinib and Encorafenib for BRAF-Mutant Melanoma
12:00am
8-K
56f9n 61njmxi1om8ya
8 May 17
Array BioPharma Announces Strategic Collaboration with Merck
12:00am
8-K
bl0uh cmqt
27 Apr 17
Shalini Sharp Joins Array BioPharma Board of Directors
12:00am
8-K
wcasyoh8ipxfbnbm
9 Feb 17
Array BioPharma Reports Financial Results For The Second Quarter Of Fiscal 2017
12:00am
8-K
7wcyp6 fhm1x
23 Dec 16
Entry into a Material Definitive Agreement
12:00am
8-K
pu3v5s1nob wrdmrx6
9 Nov 16
COLUMBUS Phase 3 Study Results in BRAF-Mutant Melanoma Presented at Society for Melanoma Research Annual Congress
12:00am
8-K
lbfhykvd
1 Nov 16
Array BioPharma Reports Financial Results For The First Quarter Of Fiscal 2017
12:00am
8-K
59g808 fpwrbmari
1 Nov 16
Submission of Matters to a Vote of Security Holders
12:00am
8-K
wbkiw5 y34jdl
28 Sep 16
Entry into a Material Definitive Agreement
12:00am
8-K
asiay 9yisab8
26 Sep 16
Array BioPharma and Pierre Fabre Announce COLUMBUS Phase 3 Study of Encorafenib plus Binimetinib For BRAF-Mutant Melanoma Met Primary Endpoint
12:00am
8-K
i0oq99x 6zt4a18q529
14 Sep 16
Array BioPharma Announces Phase 3 BEACON CRC SPA Agreement with FDA
12:00am
8-K
d6fa6ijpovlg r8ct
2 Sep 16
Entry into a Material Definitive Agreement
12:00am
8-K
dqmooa
1 Sep 16
Array BioPharma Announces FDA Acceptance of Binimetinib NDA for Patients with Advanced NRAS-Mutant Melanoma
12:00am
8-K
cl7n6
30 Aug 16
Array Presents Data from Cardiovascular Trial with ARRY-797 at the European Society of Cardiology Congress
12:00am
8-K
ope9p5lk
9 Aug 16
AstraZeneca Provides Update On Phase III Trial Of Selumetinib In Non-Small Cell Lung Cancer
12:00am
8-K
hbl9bhtoxkjz
4 Aug 16
Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2016
12:00am
8-K
f94id crc
3 Aug 16
Departure of Directors or Certain Officers
12:00am
8-K
cn3b ewec
28 Jul 16
Array BioPharma Announces Appointment Of Jason Haddock As Chief Financial Officer
12:00am
8-K
m8zpst4uec6lu0bzif
30 Jun 16
Other Events
12:00am